血源性生物标志物预测肝硬化预后研究进展
Research Progress of Blood-Derived Biomarkers Predicting Prognosis of Liver Cirrhosis
DOI: 10.12677/ACM.2023.13122775, PDF,   
作者: 胡晓丽, 文雅冰:新疆医科大学研究生院,新疆 乌鲁木齐;新疆军区总医院消化科,新疆 乌鲁木齐;孙金山:新疆军区总医院消化科,新疆 乌鲁木齐
关键词: 肝硬化预测血源性生物标志物Liver Cirrhosis Predictive Blood-Derived Biomarkers
摘要: 肝硬化(Liver Cirrhosis, LC)作为大多数慢性肝病(Chronic Liver Disease, CLD)的终末期,其死亡率较高,因此评估LC患者的预后并提供精确管理对降低死亡风险至关重要。目前已有多种评分系统用于评估LC患者的预后,但因其侵入性或主观性影响了评估的准确度。近年来,研究人员发现,血源性生物标志物对LC患者的预后有一定的预测价值。因其标本采集简单、无创并且可重复,其有望成为预测LC预后的可靠指标。本文主要对血源性生物标志物在预测LC预后功能中的作用做一综述。
Abstract: As the end stage of most chronic liver diseases (LC), cirrhosis has a high mortality rate, so assessing the prognosis of patients with chronic liver disease (CLD) and providing precise management is es-sential to reduce the risk of death. A variety of scoring systems have been used to evaluate the prognosis of patients with LC, but their invasive or subjective nature has affected the accuracy of the assessment. In recent years, researchers have found that blood-derived biomarkers have some predictive value for the prognosis of LC patients. Because of its simple specimen collection, non-invasive and repeatable, it is expected to be a reliable indicator for predicting the prognosis of LC. This review focuses on the role of blood-derived biomarkers in predicting the prognosis of LC.
文章引用:胡晓丽, 文雅冰, 孙金山. 血源性生物标志物预测肝硬化预后研究进展[J]. 临床医学进展, 2023, 13(12): 19716-19724. https://doi.org/10.12677/ACM.2023.13122775

参考文献

[1] Chavez-Pineda, O.G., Rodriguez-Moncayo, R., Cedillo-Alcantar, D.F., et al. (2022) Microfluidic Systems for the Analy-sis of Blood-Derived Molecular Biomarkers. Electrophoresis, 43, 1667-1700. [Google Scholar] [CrossRef] [PubMed]
[2] Ishikawa, T., Imai, M., Ko, M., et al. (2017) Evaluation of the Branched-Chain Amino Acid-to-Tyrosine Ratio Prior to Treatment as a Prognostic Predictor in Patients with Liver Cir-rhosis. Oncotarget, 8, 79480-79490. [Google Scholar] [CrossRef] [PubMed]
[3] Sinclair, M., Grossmann, M., Angus, P.W., et al. (2016) Low Tes-tosterone as a Better Predictor of Mortality than Sarcopenia in Men with Advanced Liver Disease. Journal of Gastroen-terology and Hepatology, 31, 661-667. [Google Scholar] [CrossRef] [PubMed]
[4] Zhang, L., Mosoian, A., Schwartz, M.E., et al. (2019) HIV Infection Mod-ulates IL-1β Response to LPS Stimulation through a TLR4-NLRP3 Pathway in Human Liver Macrophages. Journal of Leukocyte Biology, 105, 783-795. [Google Scholar] [CrossRef
[5] Dumont, A., de Rosny, C., Kieu, T.L., et al. (2019) Docosahex-aenoic Acid Inhibits Both NLRP3 Inflammasome Assembly and JNK-Mediated Mature IL-1β Secretion in 5-Fluorouracil-Treated MDSC: Implication in Cancer Treatment. Cell Death & Disease, 10, Article No. 485. [Google Scholar] [CrossRef] [PubMed]
[6] Xie, W.H., Ding, J., Xie, X.X., et al. (2020) Hepatitis B Virus X Protein Promotes Liver Cell Pyroptosis under Oxidative Stress through NLRP3 Inflammasome Activation. Inflammation Research, 69, 683-696. [Google Scholar] [CrossRef] [PubMed]
[7] Gungor, G., Ataseven, H., Demir, A., et al. (2014) Neutrophil Gelatinase-Associated Lipocalin in Prediction of Mortality in Patients with Hepatorenal Syndrome: A Prospective Ob-servational Study. Liver International, 34, 49-57. [Google Scholar] [CrossRef] [PubMed]
[8] Weichselbaum, L., Lepida, A., Marot, A., et al. (2022) Salvage Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis and Refractory Variceal Bleeding: A Systematic Review with Meta-Analysis. United European Gastroenterology Journal, 10, 874-887. [Google Scholar] [CrossRef] [PubMed]
[9] Basili, S., Raparelli, V., Napoleone, L., et al. (2018) Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study. American Journal of Gastroenterology, 113, 368-375. [Google Scholar] [CrossRef] [PubMed]
[10] Giannini, E.G., Moscatelli, A., Brunacci, M., et al. (2016) Prognostic Role of Mean Platelet Volume in Patients with Cirrhosis. Digestive and Liver Disease, 48, 409-413. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, B.K., Han, K.H., Park, J.Y., et al. (2010) Prospective Valida-tion of P2/MS Noninvasive Index Using Complete Blood Counts for Detecting Oesophageal Varices in B-Viral Cirrho-sis. Liver International, 30, 860-866. [Google Scholar] [CrossRef] [PubMed]
[12] Holecek, M. (2015) Ammonia and Amino Acid Profiles in Liver Cirrhosis: Effects of Variables Leading to Hepatic Encephalopathy. Nutrition, 31, 14-20. [Google Scholar] [CrossRef] [PubMed]
[13] Moriwaki, H., Miwa, Y., Tajika, M., et al. (2004) Branched-Chain Amino Acids as a Protein- and Energy-Source in Liver Cirrhosis. Biochemical and Biophysical Research Communica-tions, 313, 405-409. [Google Scholar] [CrossRef] [PubMed]
[14] 程静, 徐路, 彭素琼. 肝血流超声参数联合外周血vWF-Ag对肝硬化患者食管静脉曲张出血的预测价值[J]. 肝脏, 2020, 25(3): 260-263.
[15] 田勇, 张强, 梁海明, 等. 肝血流超声参数联合血清25羟维生素D3在肝硬化患者食管胃底静脉曲张破裂出血中的预测价值[J]. 医学影像学杂志, 2022, 32(11): 1935-1939.
[16] 赵明远, 武希润, 李红霞, 等. 血清25羟维生素D3的水平与肝硬化食管静脉曲张破裂出血的相关性[J]. 中华肝脏病杂志, 2019, 27(5): 358-362.
[17] Son, S.W., Song, D.S., Chang, U.I., et al. (2021) Definition of Sarcopenia in Chronic Liver Disease. Life, 11, Article 349. [Google Scholar] [CrossRef] [PubMed]
[18] Bunchorntavakul, C. and Reddy, K.R. (2020) Review Article: Malnutri-tion/Sarcopenia and Frailty in Patients with Cirrhosis. Alimentary Pharmacology & Therapeutics, 51, 64-77. [Google Scholar] [CrossRef] [PubMed]
[19] Jindal, A. and Jagdish, R.K. (2019) Sarcopenia: Ammonia Metabolism and Hepatic Encephalopathy. Clinical and Molecular Hepatology, 25, 270-279. [Google Scholar] [CrossRef] [PubMed]
[20] Lowe, R., Hey, P. and Sinclair, M. (2022) The Sex-Specific Prognos-tic Utility of Sarcopenia in Cirrhosis. Journal of Cachexia, Sarcopenia and Muscle, 13, 2608-2615. [Google Scholar] [CrossRef] [PubMed]
[21] Della, P.C., Lozanoska-Ochser, B., Renzini, A., et al. (2023) Sex Differ-ences in Inflammation and Muscle Wasting in Aging and Disease. International Journal of Molecular Sciences, 24, Arti-cle 4651. [Google Scholar] [CrossRef] [PubMed]
[22] Deng, N., Mallepally, N., Peng, F.B., et al. (2021) Serum Testosterone Levels and Testosterone Supplementation in Cirrhosis: A Systematic Review. Liver International, 41, 2358-2370. [Google Scholar] [CrossRef] [PubMed]
[23] Tandon, P., Ney, M., Irwin, I., et al. (2012) Severe Muscle Depletion in Pa-tients on the Liver Transplant Wait List: Its Prevalence and Independent Prognostic Value. Liver Transplantation, 18, 1209-1216. [Google Scholar] [CrossRef] [PubMed]
[24] Mitchell, W.K., Williams, J., Atherton, P., et al. (2012) Sarcope-nia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; a Quantitative Review. Frontiers in Physiology, 3, Article 260. [Google Scholar] [CrossRef] [PubMed]
[25] Jurado, S., Pares, A., Peris, P., et al. (2022) Bilirubin Increases Viability and Decreases Osteoclast Apoptosis Contributing to Osteoporosis in Advanced Liver Diseases. Bone, 162, Ar-ticle ID: 116483. [Google Scholar] [CrossRef] [PubMed]
[26] Ruiz-Gaspa, S., Guanabens, N., Jurado, S., et al. (2020) Bilirubin and Bile Acids in Osteocytes and Bone Tissue. Potential Role in the Cholestatic-Induced Osteoporosis. Liver Interna-tional, 40, 2767-2775. [Google Scholar] [CrossRef] [PubMed]
[27] Li, Z., Hu, J., Bao, C., et al. (2022) Activation of the NLRP3 Inflammasome and Elevation of Interleukin-1β Secretion in Infection by Sever Fever with Thrombocytopenia Syndrome Virus. Scientific Reports, 12, Article No. 2573. [Google Scholar] [CrossRef] [PubMed]
[28] 冯冬霞, 奚晶, 杨振斌, 等. 乙型肝炎肝硬化并发自发性细菌性腹膜炎患者外周血单个核细胞NLRP3和Caspase-1水平变化及其临床意义探讨[J]. 实用肝脏病杂志, 2023, 26(5): 682-685.
[29] de Carvalho, R.M. and Szabo, G. (2022) Role of the Inflammasome in Liver Disease. Annual Re-view of Pathology: Mechanisms of Disease, 17, 345-365. [Google Scholar] [CrossRef] [PubMed]
[30] Assa, A., Vong, L., Pinnell, L.J., et al. (2014) Vitamin D Deficiency Promotes Epithelial Barrier Dysfunction and Intestinal Inflammation. The Journal of Infectious Diseases, 210, 1296-1305. [Google Scholar] [CrossRef] [PubMed]
[31] Yousif, M.M., Sadek, A., Farrag, H.A., et al. (2019) Associated Vitamin D Deficiency Is a Risk Factor for the Complication of HCV-Related Liver Cirrhosis Includ-ing Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis. Internal and Emergency Medicine, 14, 753-761. [Google Scholar] [CrossRef] [PubMed]
[32] Zhang, Z., Wu, L., Wang, G. and Hu, P. (2021) Effect of Vita-min D Deficiency on Spontaneous Peritonitis in Cirrhosis: A Meta-Analysis. Przegląd Gastroenterologiczny, 16, 10-14. [Google Scholar] [CrossRef] [PubMed]
[33] Abd, E.W.A., Awadeen, A., Mansour, M.M. and Shemies, R. (2023) The Diagnostic and Prognostic Utility of Serum Cystatin C and Angiopoietin 2 in Patients with Liver Cirrhosis Compli-cated by Acute Kidney Injury. Therapeutic Apheresis and Dialysis, 27, 419-427. [Google Scholar] [CrossRef] [PubMed]
[34] Akwii, R.G., Sajib, M.S., Zahra, F.T. and Mikelis, C.M. (2019) Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology. Cells, 8, Article 471. [Google Scholar] [CrossRef] [PubMed]
[35] Cowland, J.B. and Borregaard, N. (1997) Molecular Characterization and Pattern of Tissue Expression of the Gene for Neutrophil Gelatinase-Associated Lipocalin from Humans. Genomics, 45, 17-23. [Google Scholar] [CrossRef] [PubMed]
[36] Chen, J.F., Weng, W.Z., Huang, M., et al. (2022) The Impact of Se-rum Thyroid-Stimulation Hormone Levels on the Outcome of Hepatitis B Virus Related Acute-on-Chronic Liver Failure: An Observational Study. BMC Gastroenterology, 22, Article No. 330. [Google Scholar] [CrossRef] [PubMed]
[37] Engelmann, C., Claria, J., Szabo, G., et al. (2021) Pathophysiol-ogy of Decompensated Cirrhosis: Portal Hypertension, Circulatory Dysfunction, Inflammation, Metabolism and Mito-chondrial Dysfunction. Journal of Hepatology, 75, S49-S66. [Google Scholar] [CrossRef] [PubMed]
[38] Moller, S. and Bendtsen, F. (2018) The Pathophysiology of Arteri-al Vasodilatation and Hyperdynamic Circulation in Cirrhosis. Liver International, 38, 570-580. [Google Scholar] [CrossRef] [PubMed]
[39] Tapper, E.B. and Parikh, N.D. (2023) Diagnosis and Management of Cir-rhosis and Its Complications: A Review. JAMA, 329, 1589-1602. [Google Scholar] [CrossRef] [PubMed]
[40] Wagener, G. and Bakker, J. (2015) Vasopressin in Cirrhosis and Sep-sis: Physiology and Clinical Implications. Minerva Anestesiologica, 81, 1377-1383.
[41] Rondon-Berrios, H. and Velez, J. (2022) Hyponatremia in Cirrhosis. Clinics in Liver Disease, 26, 149-164. [Google Scholar] [CrossRef] [PubMed]
[42] Bankir, L., Bichet, D.G. and Morgenthaler, N.G. (2017) Vasopres-sin: Physiology, Assessment and Osmosensation. Journal of Internal Medicine, 282, 284-297. [Google Scholar] [CrossRef] [PubMed]
[43] Szmygin, H., Szydelko, J. and Matyjaszek-Matuszek, B. (2021) Copeptin as a Novel Biomarker of Cardiometabolic Syndrome. Endokrynologia Polska, 72, 566-571. [Google Scholar] [CrossRef
[44] Alukal, J.J., John, S. and Thuluvath, P.J. (2020) Hyponatremia in Cir-rhosis: An Update. The American Journal of Gastroenterology, 115, 1775-1785. [Google Scholar] [CrossRef] [PubMed]
[45] Tan, H.Q., Zhao, M., Huang, Z., et al. (2023) Circulating Copeptin Level and the Clinical Prognosis of Patients with Chronic Liver Disease. World Journal of Gastroenterology, 29, 4797-4808. [Google Scholar] [CrossRef] [PubMed]
[46] Hartl, L., Simbrunner, B., Jachs, M., et al. (2023) An Impaired Pituitary-Adrenal Signalling Axis in Stable Cirrhosis Is Linked to Worse Prognosis. JHEP Reports, 5, Arti-cle ID: 100789. [Google Scholar] [CrossRef] [PubMed]
[47] Moreau, R., Jalan, R., Gines, P., et al. (2013) Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients with Acute Decompensation of Cir-rhosis. Gastroenterology, 144, 1426-1437.E9. [Google Scholar] [CrossRef] [PubMed]
[48] Piano, S., Tonon, M., Vettore, E., et al. (2017) Incidence, Pre-dictors and Outcomes of Acute-on-Chronic Liver Failure in Outpatients with Cirrhosis. Journal of Hepatology, 67, 1177-1184. [Google Scholar] [CrossRef] [PubMed]
[49] Suda, T., Takatori, H., Hayashi, T., et al. (2023) Plas-ma Antithrombin III Levels Can Be a Prognostic Factor in Liver Cirrhosis Patients with Portal Vein Thrombosis. Inter-national Journal of Molecular Sciences, 24, Article 7732. [Google Scholar] [CrossRef] [PubMed]
[50] Okuno, M., Kimura, Y., Taura, K., et al. (2021) Low Level of Postop-erative Plasma Antithrombin III Is Associated with Portal Vein Thrombosis after Liver Surgery. Surgery Today, 51, 1343-1351. [Google Scholar] [CrossRef] [PubMed]
[51] Ramzan, M., Iqbal, A., Murtaza, H.G., et al. (2020) Comparison of CLIF-C ACLF Score and MELD Score in Predicting ICU Mortality in Patients with Acute-On-Chronic Liver Failure. Cureus, 12, e7087. [Google Scholar] [CrossRef] [PubMed]
[52] Wang, F., Sun, W., Xiao, Q., et al. (2021) Peripheral T Lymphocytes Predict the Severity and Prognosis in Patients with HBV-Related Acute-on-Chronic Liver Failure. Medicine, 100, e24075. [Google Scholar] [CrossRef
[53] Huang, C., Li, W., Chen, C., et al. (2023) CHINAT-CD4 Score Predicts Transplant-Free Survival in Patients with Acute-on-Chronic Liver Failure. Journal of Inflammation Re-search, 16, 197-207. [Google Scholar] [CrossRef
[54] Zhang, J.Y., Zhang, Z., Lin, F., et al. (2010) Inter-leukin-17—Producing CD4+ T Cells Increase with Severity of Liver Damage in Patients with Chronic Hepatitis B. Hepatology, 51, 81-91. [Google Scholar] [CrossRef] [PubMed]
[55] Wong, Y.J., Li, J., Liu, C., et al. (2022) CHESS-ALARM Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease Patients: An International Multicenter Study. Journal of Gastroenterology and Hepatology, 37, 1043-1051. [Google Scholar] [CrossRef] [PubMed]
[56] Pons, M., Augustin, S., Scheiner, B., et al. (2021) Noninvasive Diagnosis of Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease. The American Journal of Gas-troenterology, 116, 723-732. [Google Scholar] [CrossRef] [PubMed]
[57] Garcia-Tsao, G. and Abraldes, J.G. (2021) Nonselective β-Blockers in Compensated Cirrhosis: Preventing Variceal Hemorrhage or Preventing Decompensation? Gastroenterol-ogy, 161, 770-773. [Google Scholar] [CrossRef] [PubMed]
[58] Farid, K., Omran, M.M., Farag, R.E., Arafa, M.M. and Emran, T.M. (2017) Development and Evaluation of a Novel Score for Prediction of Large Oesophageal Varices in Patients with Hepatitis c Virus-Induced Liver Cirrhosis. British Journal of Biomedical Science, 74, 138-143. [Google Scholar] [CrossRef] [PubMed]
[59] Li, F., Wang, T., Liang, J., et al. (2023) Albumin-Bilirubin Grade and INR for the Prediction of Esophagogastric Variceal Rebleeding after Endoscopic Treatment in Cirrhosis. Ex-perimental and Therapeutic Medicine, 26, Article No. 501. [Google Scholar] [CrossRef] [PubMed]
[60] Lisman, T. and Luyendyk, J.P. (2018) Platelets as Modulators of Liver Diseases. Seminars in Thrombosis and Hemostasis, 44, 114-125. [Google Scholar] [CrossRef] [PubMed]
[61] Vuille-Lessard, E., Rodrigues, S.G. and Berzigotti, A. (2021) Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease. Clinics in Liver Disease, 25, 253-289. [Google Scholar] [CrossRef] [PubMed]
[62] Oikonomou, T., Chrysavgis, L., Kiapidou, S., et al. (2023) Aspartate Aminotransferase-to-Platelet Ratio Index Can Predict the Outcome in Patients with Stable Decompensated Cirrhosis. An-nals of Gastroenterology, 36, 442-448. [Google Scholar] [CrossRef] [PubMed]
[63] Wai, C.T., Greenson, J.K., Fontana, R.J., et al. (2003) A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C. Hepatology, 38, 518-526. [Google Scholar] [CrossRef] [PubMed]
[64] Mao, W., Sun, Q., Fan, J., et al. (2016) AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients with Hepatitis B-Related Decompensated Cirrhosis. Medicine, 95, e2946. [Google Scholar] [CrossRef